NEW YORK, NY / ACCESSWIRE / October 4, 2018 / Major U.S. markets closed up on Wednesday, with the Dow Jones hitting a record high for the 15th time this year on upbeat economic data. However, market gains were trimmed later during the day with major indexes closing off intraday highs due to rising bond yields. The Dow Jones Industrial Average gained 0.20 percent to close at 26,828.39, while the S&P 500 Index jumped 0.07 percent to close at 2,925.51. The Nasdaq Composite Index climbed 0.32 percent to close at 8,025.08.
“Risk appetite has picked up recently in part because of stronger economic data and also because of progress made on trade between the U.S. and its neighboring countries, Mexico and Canada. The removal of uncertainty around trade is lifting longer-term bond yields as the prospects for growth remain intact while the Fed has yet to signal a faster pace of rate hikes,” according to Charlie Ripley, senior investment strategist at Allianz Investment Management.
RDI Initiates Coverage on:
Sarepta Therapeutics, Inc.
Tesaro's stock jumped 4.79% Wednesday, to close the day at $41.81. The stock recorded a trading volume of 1,722,312 shares, which was below its three months average volume of 1,836,218 shares. In the last year, Tesaro's shares have traded in a range of 25.62 - 125.78. The share price has gained 63.19% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $34.00 is below its 200-day moving average of $43.10. Shares of Tesaro have gained roughly 28.84 percent in the past month and are down 49.55 percent year-to-date.
Access RDI's Tesaro, Inc. Research Report at:
On Wednesday, shares of Sarepta Therapeutics recorded a trading volume of 1,873,644 shares, which was above the three months average volume of 993,746 shares. The stock ended the day 3.48% higher at $147.38. The share price has fallen 16.5% from its 52 week high with a 52 week trading range of 46.07 - 176.50. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $142.82 is above its 200-day moving average of $113.30. Shares of Sarepta Therapeutics have gained roughly 6.77 percent in the past month and are up 164.88 percent year-to-date.
Access RDI's Sarepta Therapeutics, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.